Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Expanded Access in Pancreatic Cancer”

8 trials

Showing 8 of 8 results

Not applicableAvailableNCT06872489
What this trial is testing

Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors

Who this might be right for
Neuroblastoma in ChildrenNeuroblastoma, Recurrent, RefractoryAdvanced Cancer+7 more
Second Life Therapeutics
Not applicableAvailableNCT01916148
What this trial is testing

18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia

Who this might be right for
Congenital Hyperinsulinism (CHI)Beckwith-Wiedemann SyndromeInsulinoma
Children's Hospital of Philadelphia
Not applicableNo Longer AvailableNCT05683470
What this trial is testing

Expanded Access RBS2418 Treatment

Who this might be right for
Expanded Access in Pancreatic Cancer
Riboscience, LLC.
Not applicableAvailableNCT04566393
What this trial is testing

Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies

Who this might be right for
Pancreatic CancerSmall Bowel CancerColorectal Cancer+18 more
xCures
Not applicableApproved For MarketingNCT07573215
What this trial is testing

Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic Adenocarcinoma

Who this might be right for
PDACPDAC - Pancreatic Ductal AdenocarcinomaMetastatic Pancreas Adenocarcinoma+5 more
Revolution Medicines, Inc.
Not applicableAvailableNCT07262970
What this trial is testing

Intermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a Tumor

Who this might be right for
Tumor-associated Hyperinsulinism (Tumor HI)
Rezolute
Not applicableAvailableNCT07612930
What this trial is testing

Expanded Access to PCNAT-01 for Patients With Resected Pancreatic Ductal Adenocarcinoma Following Surgical Resection and Adjuvant Therapy

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
Anda Biopharmaceutical Development (Shenzhen) Co., Ltd.
Not applicableNo Longer AvailableNCT07399015
What this trial is testing

Expanded Access to Mifomelatide for Cachexia in Adults With Advanced PDAC

Who this might be right for
Pancreatic Ductal Adenocarcinoma (mPDAC)Unresectable Pancreatic Ductal AdenocarcinomaMetastatic PDAC
Endevica Bio

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation